Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) Attenuates Interleukin-6 (IL-6)-induced Collagen Synthesis and Resultant Hypertrophy in Rat Heart

Parthenolide inhibits STAT3 signaling and attenuates angiotensin II-induced left ventricular hypertrophy via modulation of fibroblast activity

(2011) Réka Skoumal et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

High-Dose Enalapril Treatment Reverses Myocardial Fibrosis in Experimental Uremic Cardiomyopathy

(2011) Karin Tyralla et al.   PLoS One

Proinflammatory cytokines in heart failure: double-edged swords

(2010) Mona Hedayat et al.   HEART FAILURE REVIEWS

Interleukin 6 Mediates Myocardial Fibrosis, Concentric Hypertrophy, and Diastolic Dysfunction in Rats

(2010) Giselle C. Meléndez et al.   HYPERTENSION

Analysis of p53 and NF-κB signaling in modulating the cardiomyocyte fate during hypertrophy

(2010) Arunachal Chatterjee et al.   JOURNAL OF CELLULAR PHYSIOLOGY

TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure

(2010) Petra Kleinbongard et al.   PHARMACOLOGY & THERAPEUTICS

IL-17 Eliminates the Therapeutic Effects of Myelin Basic Protein-Induced Nasal Tolerance in Experimental Autoimmune Encephalomyelitis by Activating IL-6

(2010) G.-Y. Wang et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling

(2009) L Lin et al.   ONCOGENE

Molecular targets and regulators of cardiac hypertrophy

(2009) Agrawal Rohini et al.   PHARMACOLOGICAL RESEARCH

Connective tissue growth factor and cardiac fibrosis

(2008) A. Daniels et al.   Acta Physiologica